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Abstract
Plasmodium vivax is the geographically most widespread humanmalaria parasite. To analyze
patterns of microsatellite diversity and population structure across countries of different trans-
mission intensity, genotyping data from 11microsatellite markers was either generated or com-
piled from 841 isolates from four continents collected in 1999–2008. Diversity was highest in
South-East Asia (mean allelic richness 10.0–12.8), intermediate in the South Pacific (8.1–9.9)
Madagascar and Sudan (7.9–8.4), and lowest in South America and Central Asia (5.5–7.2). A
reduced panel of only 3 markers was sufficient to identify approx. 90% of all haplotypes in South
Pacific, African and SE-Asian populations, but only 60–80% in Latin American populations, sug-
gesting that typing of 2–6markers, depending on the level of endemicity, is sufficient for epide-
miological studies. Clustering analysis showed distinct clusters in Peru and Brazil, but little sub-
structuring was observed within Africa, SE-Asia or the South Pacific. Isolates fromUzbekistan
were exceptional, as a near-clonal parasite population was observed that was clearly separated
from all other populations (FST>0.2). Outside Central Asia FST values were highest (0.11–0.16)
between South American and all other populations, and lowest (0.04–0.07) between popula-
tions from South-East Asia and the South Pacific. These comparisons between P. vivax popula-
tions from four continents indicated that not only transmission intensity, but also geographical
isolation affect diversity and population structure. However, the high effective population size
results in slow changes of these parameters. This persistencymust be taken into account when
assessing the impact of control programs on the genetic structure of parasite populations.
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Author Summary
Plasmodium vivax is the predominant malaria parasite in Latin America, Asia and the
South Pacific. Different factors are expected to shape diversity and population structure
across continents, e.g. transmission intensity which is much lower in South America as
compared to Southeast-Asia and the South Pacific, or geographical isolation of P. vivax
populations in the South Pacific. We have compiled data from 841 isolates from South and
Central America, Africa, Central Asia, Southeast-Asia and the South Pacific typed with a
panel of 11 microsatellite markers. Diversity was highest in Southeast-Asia, where trans-
mission is intermediate-high and migration of infected hosts is high, and lowest in South
America and Central Asia where malaria transmission is low and focal. Reducing the
panel of microsatellites showed that 2–6 markers are sufficient for genotyping for most
drug trials and epidemiological studies, as these markers can identify>90% of all haplo-
types. Parasites clustered according to continental origin, with high population differentia-
tion between South American and Central Asian populations and the other populations,
and lowest differences between Southeast-Asia and the South Pacific. Current attempts to
reduce malaria transmission might change this pattern, but only after transmission is
reduced for an extended period of time.
Introduction
Plasmodium vivax is the human malaria parasite with the largest geographical expansion, and
the predominant malaria parasite outside of Africa [1]. Transmission intensity (according to
annual parasite incidence as a surrogate measure) ranges from very low and seasonal in tem-
perate zones and in countries approaching malaria elimination to very high mainly in Asian
and South Pacific countries [1]. Prior to malaria control starting early in the 20th century, P.
vivax transmission even occurred in large parts of Europe, Russia and the US [2]. P. vivax is
difficult to control due to relapsing liver stages, fast and constant formation of gametocytes and
a large proportion of asymptomatic carriers contributing to transmission [3, 4]. As a conse-
quence, P. vivax has become the predominant malaria parasite in several countries where P. fal-
ciparum transmission has been successfully reduced [5, 6].
Along with other parameters, parasite diversity can be used to assess the effect of interven-
tions, as reduced transmission is expected to result in reduced diversity. This relationship was
observed for P. falciparum [7, 8]. Moreover, knowledge on parasite diversity is the basis to
study gene flow between populations, or to track the source of imported infections [9]. Thus,
global comparisons of population genetic data help to develop and validate molecular tools for
surveillance of antimalarial interventions.
Typing of highly polymorphic microsatellites has proven useful to describe the diversity and
structure of parasite populations [10–14], to study patterns of relapses [15–17], multiplicity
and molecular force of infection [18, 19], and for distinguishing reinfection from recrudescence
in drug trials [20–22]. Several studies reported extensive P. vivaxmicrosatellite diversity even
in regions of moderate endemicity, and high multiplicity of infection was frequently observed.
While some P. vivax populations showed pronounced structuring on small geographical scale
[10, 13], this was not the case for other populations [11, 23].
Differences in method of sampling with respect to geographical space as well as different
panels of markers used for genotyping make direct comparison of results difficult [24]. Lacking
so far was a comprehensive comparison of P. vivax diversity based on samples collected across
many different sites and typed with the same set of markers. Therefore we compiled data from
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published studies that included samples from Peru [10], Brazil [14, 21], Sudan [25], Cambodia
[26], Vietnam [27], Papua New Guinea (PNG) and Solomon Islands [11], and complemented
this dataset with previously unpublished typing results from Central America and Mexico,
Madagascar and Central Asia (Armenia, Azerbaijan and Uzbekistan). All samples were typed
with 11 published microsatellite markers [28].
This global data set included 841 isolates from regions of different levels of transmission
intensity (Fig 1A and Table 1) and representing 6 out of 9 malaria transmission zones recently
shown to differ in relapse patterns [29]. The highest P. vivax prevalence ever has been recorded
in the lowlands of PNG (e.g. reaching>50% by PCR in children in East Sepik Province [19]).
These South Pacific parasite populations are relatively isolated due to limited migration of
human hosts. In Southeast (SE)-Asia transmission is also high, yet often focal [30]. Migration
of hosts is high SE-Asia and a major complication of eradication efforts. In Latin America
transmission is lower, but increased since the 1960s when the number of P. vivax cases was
very low due to successful spraying campaigns [5]. Transmission in Central America is low,
and parasite populations are separated from those in South America by the Isthmus of Panama,
with no road connecting South and Central America. Also within Central America sub-struc-
turing is likely; e.g. different P. vivax subpopulations were observed in Mexico, following vector
distribution [31]. In Africa, P. vivax transmission occurs mostly in Madagascar and East Africa,
i.e. Ethiopia and Sudan. In other parts of Sub-Saharan Africa P. vivax transmission is very low
as most individuals carry the Duffy-negative blood type, which largely prevents P. vivax infec-
tion [32]. Thus, Madagascan parasites are isolated from other P. vivax populations in northern
Africa, and transmission in Madagascar is relatively low. In Central Asia, transmission is very
low; in Uzbekistan malaria had been eradicated in 1961, but was reintroduced later, and is
characterized by small outbreaks in border areas [33].
The wide distribution of parasite populations included in this study permit for the first time
assessing P. vivaxmicrosatellite population structure on a global scale. Previous studies on P.
vivax population structure across different continents mostly genotyped polymorphic antigens
[34, 35] or mitochondrial DNA [36, 37]. These markers differ from microsatellites because
antigens are under immune selection and mitochondria are maternally inherited, thus exclud-
ing recombination. It remains unclear whether similar results would be obtained from analyses
of mtDNA, antigen-coding genes or of putatively neutral microsatellites. The present study
allowed a global comparison of parasite microsatellite diversity and population structure made
possible by harmonization of methods, and the definition of a minimal subset of markers for
epidemiological studies.
Methods
Ethics statement
Informed written consent was obtained from all individuals or their parents or guardians prior
to the study. Details on ethical approval are published for samples from Peru [10], Brazil [14,
21], Sudan [25], Vietnam [27], Cambodia [26] and the South Pacific [11]. For samples collected
from returning travelers to the US (samples from Central America, Mexico, Africa, India and
Indonesia) the study protocol was approved by the Ethical Committee for Research with
Human Subjects of the Institute of Biomedical Sciences, University of São Paulo (960/CEP). In
Madagascar, the study protocol was approved by the Ethics Committee of the Ministry of
Health of Madagascar (007/SANPF/2007). The study was approved by the WEHI Human
Research Ethics Committee.
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Fig 1. Origin of parasite isolates and cluster analysis. (A) The collection sites of the parasite isolates are indicated on a map of P. vivax endemicity in
2010 [1]. Note that populations named ‘Central America’, ‘Africa’, ‘Central Asia’, ‘India’ and ‘Indonesia’ include isolates from various locations within these
regions (B) Cluster analysis for K = 2 to K7. Azj = Azerbaijan, Uzb = Uzbekistan
doi:10.1371/journal.pntd.0003872.g001
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Study sites and sample collection
Details of samples included in this study are given in Table 1. In case of cohort studies, only 1
sample per individual was included. From Africa, India and Indonesia samples from returning
travelers were utilized [38]. While the number of travelers’ samples was too small to assess
intra-population diversity, linkage disequilibrium, or FST compared to other populations, they
were still useful for clustering analysis and principal component analysis (PCA).
Samples from Central America andMexico had been collected from travelers returning from
several countries spanning from Panama to Mexico. Due to the limited number of isolates and
lack of precise information on sample origin (some samples derived from travelers visiting several
countries), these isolates were combined as ‘Central American’ population, despite possible sub-
structuring. FromArmenia and Azerbaijan 14 isolates were available; these were combined because
migration between both countries is frequent and it was not always clear in which of the two coun-
tries the infection had been acquired. FromUzbekistan 20 isolates were available. For calculation of
allelic richness all Central Asian countries were pooled to reach the required number of 25 samples.
Genotyping and data analysis
All samples were typed with the same set of 11 published microsatellite markers [28]. Three
additional markers of that panel were excluded. MS3 and MS16 had not been typed in all
Table 1. Origin of samples included in study.
Population n Year Details of location Details of sample collection Published References
Peru 70 2006–
2008
Several villages around Iquitos, Peruvian Amazon Febrile patients Yes [10]
Brazil 120 2004–
2005
/2006
Granada farming settlement, next to Acrelândia,
Acre State, approx. 50 km from the border with
Bolivia
Febrile patients Yes [72]
Central America
and Mexico
27 2004–
2008
Different Central American countries and Mexico Travelers returning to the USA Yes [38]
Madagascar 60 2006–
2008
Miandrivazo and Tsiroanomandidy, approx. 100 km
apart on the central highland plateau
Febrile patients No [79]
Africa 9 2004–
2008
5 isolates from Ethiopia, 4 from across sub-
Saharan Africa
Travelers returning to the USA Yes [38]
Sudan 55 2007 Wad Medani–Gezira State (Central Sudan) and
New Halfa–Kassala State (East Sudan).
Febrile patients Partly [25]
Armenia /
Azerbaijan
14 2001–
2003
Febrile patients Partly [25]
Uzbekistan 20 2001–
2003
Febrile patients No
India 8 2004–
2008
India + 1 isolate from Bangladesh Travelers returning to the USA Yes [38]
Cambodia 87 2008 Pursat town Febrile patients Yes [26]
Vietnam 69 1999–
2000
Binh Thuan Province, central Vietnam Febrile patients identiﬁed
through active case detection
Yes [27, 30]
Indonesia 5 2004–
2008
Travelers returning to the USA Yes [38]
PNG lowlands 214 2003–
2007
North coast of PNG: Ilaita + Kunjingini (East Sepik
Province), Alexishafen (Madang province)
Ilaita: cohort study, Kunjingini /
Alexishafen: febrile children
Yes [11]
PNG highlands 37 2004–
2005
Sigimaru, southern highlands fringe Febrile children Yes [11]
Solomon Islands 45 2004–
2005
Tetere, Guadalcanal Province cross-sectional survey Yes [11]
doi:10.1371/journal.pntd.0003872.t001
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populations, and MS8 showed signals of positive selection and variation in allele sizing between
labs (details below). Microsatellites are considered neutral markers; however, some of them
might lie within coding regions or be linked to genes under selection. Selection had been tested
using Lositan software [39]. Only marker MS8 showed a weak signal for positive selection. A
relationship between P. vivaxmicrosatellite alleles and clinical disease or acquired immunity
has never been reported, thus it was not to be expected that different age groups sampled across
populations or different proportions of febrile and asymptomatic individuals would influence
population genetic parameters.
Minor differences in typing protocols did not affect the results; i.e. samples from PNG, Solo-
mon Islands, Madagascar Sudan and Central Asia were amplified by nested PCR, while a single
round of PCR was performed on all other samples. As the nested PCR primers were identical
to the single-round primers, allele sizes can be compared directly. From each lab a subset of
samples was typed again starting from DNA to ensure comparability of results. Allele lengths
were very consistent for all markers, except for MS8, where variation of up to 1.5 base pairs was
observed. Due to this variation and possible positive selection MS8 was excluded from analysis.
In case of multi-clone infections the predominant peak only was included into the analysis.
Occasionally this can result in incorrect haplotype assembly. This affects analysis such as link-
age disequilibrium or clustering, where individual haplotypes are needed. Diversity and FST
values are not affected because allelic frequencies are assessed at population level. Clustering
analysis and calculation of LD were repeated with only those samples that harbored a single
allele at each marker. To obtain sufficient samples fromMadagascar and Cambodia, we per-
mitted in the analysis also isolates with>1 alleles at one of the markers. It should be noted that
isolates of low multiplicity were selected for genotyping for several parasite populations. Thus
the difference between the number of samples of the full data set (including predominant peak
haplotypes) and the number of only single clone infections does not reflect the proportion of
multiple clone infections.
Alleles were binned using TANDEM software [40] and formatted using PGDspider [41].
Expected heterozygosity (HE) of markers and allelic richness were calculated using FSTAT
[42].HE is the chance that two unrelated parasites carry a different allele of a given marker,
and allelic richness is a measure of alleles per each marker adjusted for the different numbers
of isolates per site. When the effective population size is reduced, e.g. as consequence of intensi-
fied malaria control, rare alleles are expected to disappear first. As a result, allelic richness
changes more rapidly thanHE, as the influence of low-frequency alleles on HE is small. The
number of unique haplotypes was calculated by Dropout [43] and linkage disequilibrium (LD)
by LIAN 3.5 with 100,000-fold re-sampling [44]. LIAN compares the observed association of
markers to the values expected for random association based on the population diversity. Only
unique haplotypes with no missing data were included for calculating LD, resulting in 633 sam-
ples in this analysis. Three of the markers used (MS2, MS4, MS5) localize to chromosome 6
and two markers (MS12, MS15) to chromosome 5, thus these markers are physically linked. To
assess linkage disequilibrium irrespective of physical linkage of markers, LD was also calculated
excluding markers MS2, MS4 and MS12, i.e. with 8 markers located on 8 different chromo-
somes. As compared to the 11-marker panel, fewer isolates had to be excluded due to missing
data, but identical 8-marker haplotypes occurred more often, resulting in 637 samples for this
analysis.
Relatedness between haplotypes was assessed by pairwise comparison of all samples within
a population and calculating the proportion of shared alleles. Only samples with at least 7
markers available for comparison were included.
Effective population size Ne (i.e. the estimated number of unique haplotypes circulating in
each site) was calculated using step-wise mutations models (SMM) as well as infinite allele
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models (IAM), using mutation rates observed in P. falciparum studies of 1.5910−4 (95% confi-
dence interval = 3.710−4, 6.9810−5) [45]. While some of the markers harbor simple tri-nucle-
otide repeats, and SMM are likely applicable, other markers contain more complex repeat
structures (e.g. MS2, MS6, MS10, MS20) and IAM are more appropriate [46], thus both values
are given.
The software STRUCTURE was used to assess clustering of isolates [47]. This method
detects clusters without prior information on the origin of samples. Twenty iterations for K = 1
to K = 12 (K being the number of clusters) were run, each with a burn-in period of 10’000 steps
and then 100’000 MCMC iterations. A method developed through simulation studies [48] was
applied to estimate the most likely number of clusters. In addition, the optimal number of clus-
ters was assessed using the program STRUCTURAMA [49]. FST values among populations
were calculated using FSTAT [42]. To compute Principal Components Analysis (PCA) the
smartPCA application of EIGENSOFT was used [50]. In contrast to STRUCTURE analysis,
PCA attempts to maximize variance between populations based on the known origin of sam-
ples. While smartPCA was designed for SNPs it can be used with microsatellites; each micro-
satellite allele was treated as a SNP. Preliminary analysis had shown no population
substructuring between samples collected in Brazil in 2004 and 2006 [21], in the lowlands of
PNG [11] and in Madagascar, thus samples were combined for calculation of FST values and
PCA.
In the absence of the same measures of transmission intensity for all populations, such as
entomological inoculation rate, force of infection or parasite prevalence, populations were
broadly classified as low, medium and high transmission (Fig 2).
Results
A total of 841 P. vivax isolates were available for this study. Fig 1A shows the origin of isolates
on a published map of P. vivax endemicity in 2010, represented as parasite rate [1]. All isolates
were typed for the same set of 11 microsatellite markers. For all 841 isolates genotyping results
were obtained from7 markers. For marker MS4, no amplification product was obtained
from 70 isolates (i.e. data was obtained from 91.7% of all isolates), for all other markers data
was obtained from 823–834 (97.9–99.2%) out of 841 isolates.
Genetic diversity, linkage disequilibrium and effective population size
Pronounced differences in population diversity were observed. While expected heterozygosity
(HE) was generally high, it was strongly reduced in isolates from Uzbekistan. With the excep-
tion of Uzbekistan, HE of all except 2 markers (MS5 and MS7) was>0.5 in all populations
(Table 2, supplementary S1 File). Mean HE of 11 markers was lowest in Uzbekistan (0.52), fol-
lowed by Azerbaijan (0.67) and South America (0.68–0.71), intermediate in Africa and the
South Pacific (0.77–0.83), and highest in South-East Asia (0.84–0.87). The differences between
continents were slightly higher when only those markers with lower overall diversity were
assessed (MS1, MS4, MS5, MS7, MS12, mean HE<0.75). Mean HE ranged from 0.53 in Uzbeki-
stan and 0.6 in Peru to 0.85 in Cambodia. Mean allelic richness showed a similar pattern
(Table 2 and Fig 2) with lowest values in South America (5.5–7.0 alleles/locus) and Central
Asia (7.1 alleles/locus), intermediate values in Africa and the South Pacific (7.9–9.9 alleles/
locus), and highest in Cambodia (13.4 alleles/locus).
When all isolates and all markers were analyzed, linkage disequilibrium (LD) was strong
and significant in South American, Madagascan, Central Asian and SE-Asian populations
(Table 3). No or limited LD was detected in Central America, Sudan and the South Pacific.
Trends were similar when only single-clone infections were analyzed, with exception of Peru
Global Plasmodium vivax Population Structure
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Fig 2. Within-population diversity, LD and haplotype relatedness in relation to transmission intensity.
Transmission intensity is given in levels, low, medium and high. Diversity is given as mean allelic richness of
11 markers, based on 25 individuals (1 as for Azerbaijan and Uzbekistan few isolates were available, allelic
richness is based on 12 individuals). For LD the standardized index of association (IA
S) of given, including
only 1 marker per chromosome, and excluding identical haplotypes within populations. Relatedness shows
the mean number of alleles shared for any pair-wise comparison within a population.
doi:10.1371/journal.pntd.0003872.g002
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and Madagascar, where LD observed in the analysis of all data was no longer detected. Overall
levels of LD were lower in the single-clone data set. This can be explained by the reduction in
sample size, since similarly low levels of LD were observed in an equally low number of ran-
domly selected multi-clone infections. Most representative results were obtained when only 1
marker per chromosome was included, thus excluding physical linkage of markers (total of 8
markers). All populations in the South Pacific, Peru, Central America and Sudan were in full
linkage equilibrium (Table 3 and Fig 2).
Effective population Ne size was about twice as high in Cambodia and Vietnam (IAM: 6378
and 5553) as compared to South America (2423–2829, Table 4). Values for Madagascar, Sudan
and the South Pacific were intermediate, and low for Azerbaijan (2422) and Uzbekistan (1606).
Estimates based on SMM were 2–3 fold higher. Samples from Central America and Mexico
were highly diverse and showed high Ne (5159), likely because they originated from different
countries and thus represent different subpopulations.
Haplotype diversity
Across all populations a total of 759 individual haplotypes were found in 818 isolates. 11-loci
haplotypes were shared only within the same country. Again isolates from Uzbekistan were
Table 2. Diversity of 11 microsatellite loci.
Population Sub-population N Mean HE 11
markers
Mean HE 5 markers (HE
<0.8)1
Mean number of
alleles
Mean allelic
Richness2
South America Combined 190 0.79 0.72 11.73 8.99
Peru 70 0.71 0.6 7.64 6.99
Brazil Combined 120 0.74 0.7 9.27 7.21
Brazil 2004 42 0.68 0.63 5.73 5.48
Brazil 2006 78 0.70 0.69 8.09 6.82
Central America and
Mexico
27 0.84 0.78 10.09 10.07
Madagascar Combined 60 0.80 0.74 10.09 9.10
Miandrivazo 28 0.80 0.73 7.91 7.89
Tsiroano-
mandidy
32 0.78 0.72 8.45 8.33
Sudan 55 0.76 0.71 9.36 8.43
Central Asia Combined 34 0.75 0.74 7.27 7.16
Azerbaijan 14 0.67 0.66 4.09 NA3
Uzbekistan 20 0.52 0.54 4.36 NA3
Cambodia 87 0.87 0.85 16.18 12.81
Vietnam 69 0.84 0.8 11.45 10.08
PNG lowlands Combined 214 0.80 0.74 14.91 10.15
Iliata 132 0.79 0.7 12.55 9.58
Kunjingini 38 0.81 0.72 8.36 8.15
Alexishafen 44 0.83 0.77 10.64 9.94
PNG highlands 37 0.82 0.78 8.82 8.56
Solomon Islands 46 0.81 0.77 8.91 8.44
Detailed data for all markers and all populations can be found in Supplementary S1 File.
1 Includes markers MS1, MS4, MS5, MS7, MS12
2 Mean allelic richness is based on 25 individuals
3 Not available, as number of samples <25
doi:10.1371/journal.pntd.0003872.t002
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Table 3. Linkage disequilibrium.
Population Sub-population All isolates Single-clone infections 1 marker/chromosome1
n2 IAS P n2 IAS P n2 IAS P
Peru 52 0.032 2.1 x 10−4 17 0.007 0.31 44 0.005 0.33
Brazil Combined4 111 0.069 <10−5 32 0.036 <10−5 81 0.028 <10−5
Brazil 2004 35 0.130 <10−5 14 0.090 1.1 x 10−4 26 0.059 1.3 x 10−4
Brazil 2006 76 0.071 <10−5 18 0.088 <10−5 58 0.031 10−4
Central America and Mexico 27 0.020 0.027 NA 27 -0.005 0.62
Madagascar Combined5 53 0.033 <10−5 12 -0.008 0.67 52 0.025 3 x 10−4
Miandrivazo 24 0.057 <10−5 NA 24 0.030 0.016
Tsiroanomandidy 29 0.062 <10−5 NA 30 0.036 1.5 x 10−3
Sudan 36 0.013 0.051 18 0.001 0.48 38 -0.011 0.89
Central Asia 10 0.203 <10−5 9 0.179 <10−5 15 0.163 <10−5
Cambodia 87 0.011 4.3 x 10−4 17 0.035 0.013 86 0.012 2.1 x 10−3
Vietnam 43 0.078 <10−5 NA 44 0.023 1.1 x 10−3
PNG lowlands Combined6 163 0.003 0.085 67 0.001 0.43 184 -0.001 0.68
Iliata 91 0.000 0.49 28 0.001 0.43 110 0.000 0.5
Kunjingini 31 0.011 0.047 14 0.033 0.028 36 0.008 0.14
Alexishafen 41 0.010 0.036 25 0.000 0.47 41 -0.002 0.59
PNG highlands 29 0.017 0.015 8 0.036 0.11 30 -0.009 0.85
Solomon Islands 22 0.002 0.44 NA 36 0.005 0.26
1 includes 8 microsatellite markers located on 8 different chromosomes
2 n = number of unique isolates (no identical haplotype in the same population) without missing data; this was the data analyzed
doi:10.1371/journal.pntd.0003872.t003
Table 4. Effective population size.
Population Sub-population IAM SMM
Peru 2829 [1216–6443] 5373 [2309–12239]
Brazil Combined 3429 [1473–7810] 7167 [3080–16326]
Brazil 2004 2423 [1041–5519] 4289 [1843–9771]
Brazil 2006 2598 [1116–5917] 4743 [2038–10805]
Central America and Mexico 5159 [2217–11753] 13625 [5855–31036]
Madagascar Combined 4373 [1879–9961] 10453 [4492–23812]
Miandrivazo 4327 [1859–9856] 10280 [4418–23418]
Tsiroanomandidy 3837 [1649–8739] 8517 [3660–19401]
Sudan 4829 [2075–11000] 12245 [5262–27894]
Azerbaijan 2422 [1041–5517] 4287 [1842–9766]
Uzbekistan 1606 [690–3658] 2426 [1043–5527]
Cambodia 6378 [2741–14529] 19315 [8300–43999]
Vietnam 5553 [2386–12649] 15359 [6600–34987]
PNG lowlands Combined 4626 [1988–10539] 11433 [4913–26044]
Iliata 4192 [1801–9549] 9780 [4203–22277]
Kunjingini 4659 [2002–10614] 11563 [4969–26340]
Alexishafen 5092 [2188–11598] 13336 [5731–30378]
PNG highlands 5010 [2153–11412] 12991 [5583–29593]
Solomon Islands 4675 [2009–10649] 11624 [4995–26480]
doi:10.1371/journal.pntd.0003872.t004
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unusual, as 10 out of 20 isolates were identical and another two shared the same haplotype.
Ten haplotypes were observed more than once in Peru, 5 and 2 in Brazil in 2004 and 2006
(plus 1 shared between the 2004 and 2006 data set), 5 in Sudan, 2 in Azerbaijan, 2 in Vietnam
(1 observed 5 times), and 1 in PNG. 730/818 haplotypes were singletons.
Relatedness among haplotypes was calculated for each population (Fig 2). In the pairwise
comparisons isolates from Cambodia and Vietnam shared the same allele on average in 12.6%
and 15.0% of markers (i.e. a mean of 1.4 and 1.65 out of 11 microsatellites carried the same
allele). Samples from Central American, African and South Pacific populations shared the
same allele in 16.5–22.5% of markers. Relatedness was 29.3–32.5% in South American popula-
tions, and in Azerbaijan 33.3% and in Uzbekistan 48.5% of markers shared the same allele.
To assess discrimination power of a smaller panel of markers compared to the full set of
markers, microsatellites were removed successively and haplotype counts recorded from each
individual population, as well as for the full dataset (Fig 3). MS4 was removed first, as no data
for this marker could be obtained from 70 isolates. The remaining 10 markers were sequentially
removed according to their diversity across all populations, starting with the least diverse one.
Only taking into account haplotypes shared within populations, a set of 4 markers (MS2,
MS9, MS15, MS20) identified 710/760 (93.4%) haplotypes and 3 markers (MS2, MS15, MS20)
still identified 665/760 (87.5%) haplotypes. By reducing to 2 markers (i.e. MS15 and MS10),
the number of haplotypes dropped considerably to 513/760 (67.5%). The proportion of haplo-
types lost by omitting markers was highest in South American populations. When using only 3
markers, 13–38% of haplotypes were lost in South American populations, but<10% in popula-
tions from SE-Asia and the South Pacific (Fig 3).
Taking into account haplotypes observed in several populations, a single haplotype was
shared between Peru and Vietnam when the panel was reduced to 5 markers. With four mark-
ers 15 additional haplotypes were shared. While some were shared between populations from
the same continent (5 identical 4-loci haplotypes in 251 isolates from PNG), 11 haplotypes
occurred on different continents (e.g. Peru/Azerbaijan, Madagascar/Vietnam, Brazil/Cambo-
dia/Vietnam, Sudan/Solomon Islands). As a consequence, when haplotypes shared between
populations were taken into account, 4 markers identified 687/759 (91.5%) haplotypes, and 3
markers 595/759 (78.4%) haplotypes (black line in Fig 3, panel 1).
Population structure
Clustering analysis indicated clearly distinct clusters, mainly following geographical lines (Fig
1B). First South American samples (but not those from Central America) and samples from
Azerbaijan were separated from all other populations, with admixture in samples from Central
America and Africa. When the number of clusters (K) was 3, the South Pacific populations
formed a separate cluster, as well as the Brazilian samples, while samples from Peru, Central
America, Madagascar and Asia clustered together. Peruvian samples formed a separate cluster
when K was set to 4, K = 5 led to the separation of Madagascar, Sudan and Azerbaijan from
SE-Asia. Central American samples formed an individual cluster when K = 6. The clonal popu-
lation in Uzbekistan clustered with different populations in individual STRUCTURE runs for a
given value of K, indicating that no clear relationship to any other population was observed.
When the optimal number of clusters was calculated as described [48], high values were
observed for K = 2, K = 5 and K = 7 (Fig 4). In addition the program STRUCTURAMA was
used to assess the best number of clusters. The 99% CI for estimates of cluster number showed
a wide range (79–115 clusters) and was thus not informative
As the clear separation of Latin American and South Pacific isolates from those from Africa
and Asia might interfere with more subtle population structure within Africa and Asia,
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Fig 3. Loss of discrimination power between haplotypes with a reduced panel of markers.Markers
were sequentially removed (X-axis: number of remaining marker and marker removed), and the percentage
Global Plasmodium vivax Population Structure
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003872 June 30, 2015 12 / 23
clustering analysis by STRUCTURE was repeated including the latter isolates only (Fig 5A).
For K = 2 African and Azerbaijani isolates clustered separately from SE-Asian ones. Indian iso-
lates clustered with Africa. As with the full set of isolates, the clonal samples from Uzbekistan
clustered with different populations in individual runs for the same number of clusters (e.g.
with Africa or with SE-Asia if K = 2). For K = 3 these isolates formed a separate cluster. Both
within Africa and SE-Asia admixture was high, and when the number of clusters was set to 4 or
5, the separation between countries was limited. Analysis with STRUCTURE was repeated for
single clone infections only. Results were similar as for the full data set (Fig 5B).
Results of clustering analysis were confirmed by FST values (Table 5). Between Brazil and
Peru FST values were high (0.16), as well as when South American populations were compared
to non-American populations (0.11–0.29). Differences between Cambodia, Vietnam and South
Pacific populations were lowest (0.026–0.066). The highest FST value was observed between
Azerbaijan and Uzbekistan (0.37), and all values for comparisons between Uzbekistan and
other populations were>0.2. FST between Madagascar and Sudan was low (0.07).
FST values were also compared between continents or sub-continents, i.e. South America,
Africa, Central Asia, SE-Asia and the South Pacific (Table 6). FST was highest between South
America and the South Pacific as well as between Central Asia and all other populations (0.11),
and lowest between SE-Asia and the South Pacific (0.042) and SE-Asia and Africa (0.058).
In principal component analysis (PCA), PC1 differentiated isolates from Brazil and Peru on
the one hand and the South Pacific on the other hand from a cluster containing African and
Asian isolates (Fig 6). PC2 separated isolates from Peru und Brazil.
In summary, clustering analysis, FST values and PCA showed similar results. South Ameri-
can populations were separated from all others, and populations from Brazil and Peru formed
clearly separated groups with little admixture. African, SE-Asian and South Pacific populations
each formed a large cluster with little sub-structuring. Samples from Central America, Indone-
sia and India grouped with SE-Asia.
of individual haplotypes as compared to the 11-marker panel was counted. n = number of isolates per
population, h = number of individual haplotypes identified with the 11-marker panel. ‘World’ shows the
number of haplotypes when those shared between populations were counted only once.
doi:10.1371/journal.pntd.0003872.g003
Fig 4. Optimal number of clusters. The optimal number of clusters for the STRUCTURE analysis shown in
Fig 1 was calculated as described [48].
doi:10.1371/journal.pntd.0003872.g004
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Discussion
Analysis of 841 P. vivax isolates of global origin, typed with the same markers, allowed direct
comparison between populations differing in transmission intensity, geographical isolation
and history of malaria control. Determination of the optimal set of microsatellite markers
required for differentiation of individual parasite infections will improve strategies for genotyp-
ing. Knowledge on population structure can be used to assess the effect of interventions and
help to track imported infections.
Fig 5. STRUCTURE analysis with African and Asian isolates only (A), and with single clone infections only (B).
doi:10.1371/journal.pntd.0003872.g005
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Selection of molecular markers for epidemiological studies
Diversity of a marker, expressed as expected heterozygosity (HE), is a key criterion for choosing
a subset of microsatellite markers for a variety of genotyping questions [51]. Markers of a lower
diversity are more suitable to assess population structure, as with less diverse markers, a smaller
number of isolates is needed to detect genetic differences among populations. In contrast,
many applied genotyping studies aim at distinguishing between “identical” and “different”
clones. Samples from treatment failures in a drug trial for example require distinction between
new infection versus recrudescence (reappearance of a pre-treatment clone) [18–22]. In this
scenario the phylogenetic relationship of genotypes observed is not of interest. Such applied
typing tasks often include large numbers of isolates, and thus a minimal set of markers is desir-
able that is able to reduce the genotyping workload and price without impairing the discrimi-
nation power for distinguishing clones. For phylogeographical studies a larger panel of
markers is needed. The same is required for tracking the origin of imported malaria cases.
The step-wise removal of markers showed that as little as 3 highly diverse markers were suf-
ficient to detect around 90% of all haplotypes in most populations, only in South American
populations up to 40% of haplotypes were missed. Thus, typing only 2–3 markers in SE-Asia,
the South Pacific and Africa, and 4–6 markers in South America would lead to only a small
underestimation of multiplicity of infection or of treatment efficiency (when a clone during fol-
low-up could not be distinguished from the clone at baseline and a new infection was taken for
a recrudescence).
Table 5. Differentiation of populations (FST values).
Peru Brazil Central
America
Madagascar Sudan Azerbaijan Uzbekistan Vietnam Cam-
bodia
PNG
lowlands
PNG
highlands
Brazil 0.159
Central
America
0.107 0.095
Madagascar 0.139 0.125 0.080
Sudan 0.118 0.142 0.078 0.069
Azerbaijan 0.208 0.202 0.167 0.140 0.148
Uzbekistan 0.289 0.279 0.250 0.234 0.246 0.367
Vietnam 0.109 0.116 0.062 0.071 0.078 0.141 0.206
Cambodia 0.124 0.136 0.074 0.089 0.096 0.173 0.224 0.032
PNG lowlands 0.163 0.155 0.097 0.115 0.109 0.154 0.215 0.066 0.055
PNG
highlands
0.160 0.148 0.085 0.110 0.106 0.175 0.237 0.045 0.042 0.026
Solomon
Islands
0.146 0.139 0.096 0.079 0.102 0.165 0.227 0.066 0.058 0.061 0.055
All FST values are signiﬁcant.
doi:10.1371/journal.pntd.0003872.t005
Table 6. FST values among continents.
South America Africa Central Asia SE-Asia
Africa 0.077
Central Asia 0.139 0.105
SE-Asia 0.078 0.058 0.111
South Paciﬁc 0.111 0.083 0.111 0.042
All FST values are signiﬁcant.
doi:10.1371/journal.pntd.0003872.t006
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Other limitations affect drug trial results, such as imperfect detectability of minority clones
[52] and as a consequence substantial day-to-day variation in the alleles detected [53]. Longitu-
dinal P. vivax studies involving genotyping are also complicated by relapsing hypnozoites,
which can be homologous or heterologous to the clone at baseline [16, 54]. Longitudinal stud-
ies can also be affected by re-infection with a genotype observed earlier in the same individual.
This is a particular threat when the overall diversity in the parasite population is low, as
observed in Uzbekistan, or in case of clonal expansion during an outbreak [46]. Thus, when
the population diversity is intermediate or high, using a reduced panel of markers is acceptable
as this reduces the ability to differentiate clones only in a minor way and is justified in view of
substantial savings in time and costs.
Transmission intensity shapes population parameters
Overall parasite diversity measured asHE or allelic richness was high and reflected transmis-
sion levels. It was lowest in South America and Central Asia, where transmission is low, and
highest in SE-Asia. In the South Pacific diversity was intermediate despite highest levels of
transmission (prevalence>50% in Ilaita [19]). This could be due to the relative geographical
isolation of South Pacific populations, and thus limited introduction of parasites from other
regions. In contrast migration of infected hosts is high among SE-Asian countries, thus high
parasite diversity can be maintained, even when transmission is reduced.
Linkage disequilibrium can be the result of selfing in the mosquito of male and female gam-
etes from the same parasite clone [55], as opposed to recombination of different clones result-
ing in a break up of linkage. Recombination can occur if a mosquito feeds on a host infected
with different parasite clones. The level of LD is expected to decrease with increasing
Fig 6. Principal component analysis. Each symbol represents a parasite haplotype, the symbol and color have been assigned according to the geographic
origin. Identical haplotypes resulted in the same coordinates in PCA, and are represented by a single symbol; thus the number of symbols plotted does not
correspond to the total number of parasite samples analyzed.
doi:10.1371/journal.pntd.0003872.g006
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transmission intensity, while diversity is expected to increase. In line with this expectation, LD
was detected in Brazil, Central Asia and Madagascar, where transmission is low [1]. It is, how-
ever, noteworthy that levels of diversity did not fully correlate with transmission intensity.
Highest diversity and strong LD was observed in SE-Asia. In the South Pacific an intermediate
diversity but no LD was found. Different processes influence diversity and LD; likely the local
ecology add to the high parasite diversity in SE-Asia, while the high proportion of individuals
carrying multi-clone infections in the South Pacific (up to 75% of all infected [19]) lead to high
levels of parasite recombination. High LD is also expected when closely related parasites are
sampled. Yet no LD was observed in Ilaita in PNG, despite most dense sampling of all popula-
tions with 132 isolates collected across hamlets approx. 5 km from each other [56].
Incorrect assembly of multi-locus haplotypes in multi-clone infections within a host would
be expected to lead to incorrect low levels of LD, but the opposite trend was observed: lower
LD was found when only single-clone infections were included in the analysis. This unexpected
finding was attributed to the smaller sample size after removing multi-clone infections.
Analysis of population structure revealed significant FST values between all populations.
While clustering analysis and PCA differentiated among those populations separated by high
FST values, no within-continent subdivision was observed in the South Pacific, Africa and
SE-Asia. The difference in clustering between populations from Latin American (clearly sepa-
rated clusters in Peru, Brazil and Central America and Mexico) on the one hand and from the
South Pacific (no subdivision between different provinces in PNG and Solomon Islands) or
Africa (no subdivision between Madagascar and Sudan) on the other hand is striking, given
comparable distances between sites. While high levels of human migration in SE-Asia could
explain parasite gene flow, no clusters were found in the South Pacific despite limited human
movement (only air and sea transport between East Sepik and Madang provinces, and between
PNG and Solomon Islands). Likewise limited sub-structuring was evident between Madagascar
and Sudan, despite open sea and countries with very low P. vivax transmission separating sam-
pling locations. In Central Asia, clear subdivision was observed between parasites east and west
of the Caspian Sea. Parasites from Azerbaijan and Armenia clustered with those from Africa,
while parasites from Uzbekistan were highly clonal and formed a separate cluster.
Distinct parasite subpopulations might be the result of expansion of parasite clones after the
near elimination of malaria in the second half of the 20th century in some countries. In Latin
America they could also reflect different independent introductions of P. vivax, as it has been
shown for P. falciparum [57]. In Uzbekistan P. vivax had been reintroduced after its elimina-
tion, most likely from other Central Asian countries. In contrast, in SE-Asia and the South
Pacific P. vivax was present much longer than in Latin America, and even during the peak of
the eradications campaigns in the 1960s prevalence remained high [58]. Central American and
Mexican samples were exceptional as they were highly diverse and LD was low despite low
transmission intensity. This is most likely caused by the fact that these samples represent differ-
ent isolated subpopulations over a large geographical range. Further studies involving addi-
tional parasite populations and different molecular markers are needed to establish differences
between South and Central American samples, to understand why Central America clusters
with SE-Asia, and to identify potential routes for P. vivax colonization of South and Central
America.
Beside microsatellites, other molecular markers have been used to assess P. vivax population
structure, most importantly mtDNA and polymorphic antigens. In agreement with the present
study, sequencing of mtDNA identified a separate subgroup in Latin America (highest support
of all subgroups in Bayesian tree analysis) [36], as well as highly diverse populations in Asia
and the South Pacific [37]. However, no pronounced separation between South-Pacific, SE-A-
sian and some South American isolates was observed using mtDNA [36]. Isolates from South
Global Plasmodium vivax Population Structure
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003872 June 30, 2015 17 / 23
and Central America had been found in the same subgroup, yet, only 3 haplotypes from Cen-
tral America were sequenced [36]. The same study found different subgroups in East Asia
(China and Korea) and SE-Asia (Cambodia, Thailand and Indonesia), plus a third subgroup
including isolates from locations across Asia and PNG. The present study includes no isolates
from China or Korea, and only few from Indonesia, thus no such structure within East Asia
could be found.
In concordance with microsatellite results, mtDNA diversity was highest in SE-Asia and
high in the South Pacific [36]. In contrast to microsatellite-derived measurements of diversity,
mtDNA diversity was lower for Madagascar, Central America and Africa, whereby results of
the latter two populations are likely affected by a very small sample size [36]. The same study
indicated that overall P. vivax diversity in Latin America was as high as in SE-Asia, despite
locally reduced diversity, a result confirmed by analysis of 3 whole-genome sequences from
Latin America [59]. The present study found microsatellite diversity across Central America
and Mexico to be similarly high as that of SE-Asia, but when isolates from Peru and Brazil
were combined diversity remained lower.
SNPs in antigens are expected to be under strong balancing selection, limiting their use to
study the underlying population structure. In line with this, many antigens showed strong clus-
tering but in contrast to microsatellites many clusters were shared between continents [34, 35].
Like microsatellites, AMA-1 and MSP-1 alleles from South Pacific populations showed very lit-
tle admixture with any other parasite populations [34, 60]. DBP-II alleles in contrast were
more evenly distributed across continents [35]. A study using putatively neutral SNPs covering
a 200-kb genomic region confirmed subdivision between Brazil and SE-Asia [61], and a bar-
code of 42 SNPs across the genome was recently published and tested on a small number of
clinical samples from three continents [62]. However, this barcode was not yet tested for assess-
ing local population structure or for typing asymptomatic, low-density infections.
Application of genotyping in malaria control
Continuous malaria control is expected to reduce parasite diversity and effective population
size, and to increase differences between populations due to clonal expansion of remaining par-
asite strains [63]. Indeed, near-clonal expansion of parasites has been observed for P. falcipa-
rum in the highlands of PNG [8], in Solomon Islands [64] and in South America [7]. Likewise,
Artemisinin-resistant clones have expanded in SE-Asia [65].
In striking contrast to these findings, nearly all studies assessing P. vivax diversity found
high parasite diversity, even in countries now aiming to eliminate malaria [66–69]. The clonal
expansion in Uzbekistan, a country that had successfully eliminated malaria in the 1960-ies, is
the first such population structure reported for P. vivax. Low microsatellite diversity was also
found in South Korea, where transmission has been low for decades and the parasite popula-
tion is relatively isolated [70], as well as from a rural, isolated site in Peru [71]. The high P.
vivax diversity in countries with low transmission likely indicates a high underlying effective
population size and thus a large number of infected individuals. Two hallmarks of P. vivax biol-
ogy add to this, namely hypnozoites in the liver, and a large proportion of asymptomatic, low-
density infections that escape screenings conducted by light microscopy or rapid diagnostic
test and thus a substantially underestimated parasite reservoir [4].
The isolates studied here were collected prior to the renewed call for malaria elimination.
Only few studies have typed samples collected after up-scaling control measures, but diversity
remained high [72–74]. It seems that control has little short-term effect on population size, and
diversity measures changes slowly as long as the effective population size remains high (above
100 genetically distinct parasite clones) [75]. Therefore diversity measures will only be useful
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to assess the impact of control programs once transmission is very low after several years of
intensified control.
In recent years malaria control has been intensified reducing prevalence and incidence in
PNG [76], many Asian countries [69, 77] and South America [78]. It will be important to eval-
uate whether reduced prevalence is paralleled by increased sub-structuring on small scale, i.e.
breaking up of the South Pacific and SE-Asian clusters, indicating local hotspots of transmis-
sion. A pronounced reduction of genetic diversity and increase in population structure will
implicate success of control and interruption of parasite gene flow from neighboring
populations.
In previously malaria-free regions, microsatellite typing can help to study outbreaks.
Because of their high discrimination power between clones, genotyping outbreak samples can
clarify whether a single clone was imported and spread across a local region, or whether steady
gene flow from neighboring regions with ongoing transmission occurs, resulting in a diverse
parasite population [9].
Conclusions
Microsatellite typing remains an important tool to study P. vivax, as it can be done in any lab
equipped for PCR. For epidemiological studies and drug trials, a limited set of 2–6 markers,
depending on transmission intensity, provides sufficient resolution to distinguish individual
clones. The full panel of 11 microsatellite markers showed clear population structure on a
global scale, and differences in diversity reflect transmission intensity and isolation of parasite
populations. These population genetic measures could potentially be used as tools to measure
the impact of control programs; however, due to the large effective population size even in
countries of moderate endemicity, these parameters are likely to change slowly.
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